Track the 인벤티지랩 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 인벤티지랩 has recorded 67 insider filings. The latest transaction was reported on 29 June 2026 (Purchase). Among the most active insiders: 류충호. Every trade is free.
67
Insider Decl.
n/a
Thresholds
n/a
33 ops.
Buy Volume
n/a
13 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
InvenTige Lab is a company in the health and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance healthcare.